Last reviewed · How we verify

NCT01605578

Description of Abdominal and Gluteo-femoral Subcutaneous Adipose Tissue Cell Population in Women - GLUTAB

Completed NA Last updated 4 September 2025
What this trial tests

NA trial testing Biopsies in Adipose Tissue in 20 participants. Completed in 14 December 2012.

Timeline
14 May 2012
Primary endpoint
14 December 2012
14 December 2012

Quick facts

Lead sponsorInstitut National de la Santé Et de la Recherche Médicale, France
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Primary purposebasic science
Enrollment20
Start date14 May 2012
Primary completion14 December 2012
Estimated completion14 December 2012
Sites1 location across France

Drugs / interventions tested

Conditions studied

Sponsor

Institut National de la Santé Et de la Recherche Médicale, France — full company profile →

Who can join

Adults 25 to 45, female only, with Adipose Tissue. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this study is to compare, in healthy women, the adipose tissue composition between abdomen and thigh and then determine whether differences exist independently of the state of obesity. The findings of this study may help to explain the mechanism contributing to a beneficial role of gluteo-femoral fat contrasting with a deleterious role of abdominal fat on cardiovascular and metabolic dysfunctions.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Biopsies

Trials testing the same drug.

Other recruiting trials for Adipose Tissue

Currently open trials in the same condition.

Other Institut National de la Santé Et de la Recherche Médicale, France trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT01605578.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing